Anagliptin is a pharmaceutical drug for the treatment of type 2 diabetes mellitus.
This report contains market size and forecasts of Anagliptin API in global, including the following market information:
- Global Anagliptin API Market Revenue, 2018-2023, 2023-2030, ($ millions)
- Global Anagliptin API Market Sales, 2018-2023, 2023-2030, (Kg)
- Global top five Anagliptin API companies in 2022 (%)
The global Anagliptin API market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
99.0% Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Anagliptin API include Lepu Medical Technology ( Beijing ) Co., Ltd, Bowa Sunshine, Jinan Lead Pharmaceutical Technology Co., LTD., Honour Lab Limited, DEAFARMA, Dr. Reddys API and NEWEDGE Overseas, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Anagliptin API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anagliptin API Market, by Type, 2018-2023, 2023-2030 ($ Millions) & (Kg)
Global Anagliptin API Market Segment Percentages, by Type, 2022 (%)
Global Anagliptin API Market, by Application, 2018-2023, 2023-2030 ($ Millions) & (Kg)
Global Anagliptin API Market Segment Percentages, by Application, 2022 (%)
Global Anagliptin API Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions) & (Kg)
Global Anagliptin API Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Anagliptin API revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies Anagliptin API revenues share in global market, 2022 (%)
- Key companies Anagliptin API sales in global market, 2018-2023 (Estimated), (Kg)
- Key companies Anagliptin API sales share in global market, 2022 (%)
key players include:
- Lepu Medical Technology ( Beijing ) Co., Ltd
- Bowa Sunshine
- Jinan Lead Pharmaceutical Technology Co., LTD.
- Honour Lab Limited
- DEAFARMA
- Dr. Reddys API
- NEWEDGE Overseas
